Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy

被引：2
|
作者：
Cho, B. C. [1 ]
Aguado de la Rosa, C. [2 ]
Vila, L. [3 ]
Isla, D. [4 ]
Oliveira, J. [5 ]
de Castro Carpeno, J. [6 ]
Tomova, A. [7 ]
Kim, T. M. [8 ]
Blasco Cordellat, A. [9 ]
Bauchet, A-L. [10 ]
Soufflet, C. [11 ]
Bensfia, S. [12 ]
Dy, G. [13 ]
机构：
[1] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[2] Hosp Clin San Carlos, Madrid, Spain
[3] Parc Tauli Hosp Univ, Barcelona, Spain
[4] Hosp Clin Lozano Blesa, Zaragoza, Spain
[5] Inst Portugues Oncol Porto Francisco Gentil EPE, Porto, Portugal
[6] Hosp Univ La Paz, Madrid, Spain
[7] Complex Oncol Ctr Plovdiv, Plovdiv, Bulgaria
[8] Seoul Natl Univ Hosp, Seoul, South Korea
[9] Hosp Univ Valencia, Valencia, Spain
[10] Sanofi, Chilly Mazarin, France
[11] Sanofi, Boulogne, France
[12] Sanofi, Cambridge, MA USA
[13] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1965
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1364TiP
引用
收藏
页码：S1034 / S1035
页数：2
相关论文
共 50 条
  • [31] Camrelizumab plus platinum doublet chemotherapy as adjuvant treatment of stage IIA-IIIA non-small cell lung cancer: A phase II, single-arm research
    Xu, H.
    Kong, X.
    Zhao, S.
    Zhu, K.
    Shi, B.
    Wang, Y.
    Ni, B.
    Han, B.
    Hou, J.
    Bu, J.
    Gu, Y.
    Ren, F.
    Xu, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S1621 - S1621
  • [32] Bevacizumab plus platinum-based chemotherapy in advanced non-squamous non-small-cell lung cancer: a randomized, open-label phase 2 study (CLEAR)
    Udagawa, Hibiki
    Sugiyama, Eri
    Harada, Toshiyuki
    Atagi, Shinji
    Koyama, Ryo
    Watanabe, Satoshi
    Nakamura, Yukiko
    Harada, Daijiro
    Hataji, Osamu
    Tanaka, Fumihiro
    Kida, Hiroshi
    Satouchi, Miyako
    Maeno, Ken
    Inoue, Akira
    Yoh, Kiyotaka
    Yamane, Yuki
    Urata, Yoshiko
    Yoshioka, Hiroshige
    Yamanaka, Takeharu
    Goto, Koichi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3059 - +
  • [33] Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy
    Leu, KM
    Kim, KM
    Larson, M
    Larson, M
    Schiller, JH
    LUNG CANCER, 2001, 34 (01) : 105 - 113
  • [34] Anlotinib in elderly patients with advanced non-squamous non-small cell lung cancer (NSCLC) who had not received systemic chemotherapy: A single-arm, multi-center, phase II study
    Zhao, D.
    Hou, X.
    Li, Z.
    Yang, L.
    Hou, X.
    Li, H.
    Yan, L.
    Liu, H.
    Li, Z.
    Liu, X.
    Song, F.
    Li, G.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S1022 - S1022
  • [35] Phase II pharmacodynamic trial of erlotinib in advanced non-small cell lung cancer (NSCLC) patients previously treated with platinum-based chemotherapy
    Felip, E
    Rojo, F
    Heller, A
    Foernzler, D
    Majo, J
    Klughammer, B
    Ramos, J
    Maacke, H
    Brennscheidt, U
    Baselga, J
    LUNG CANCER, 2005, 49 : S369 - S369
  • [36] Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trial
    Gao, Ming
    Zhang, Xia
    Yan, Huan
    Zhao, Yan
    Yuan, Fang
    Sun, Decong
    Yang, Xuejiao
    Ju, Yanfang
    Wang, Lijie
    Tao, Haitao
    Tian, Luyuan
    Zhao, Changhong
    Ma, Junxun
    Hu, Yi
    Liu, Zhefeng
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2025, 17
  • [37] Efficacy and safety of DCVAC/LuCa Treatment plus standard chemotherapy and TCM in patients with advanced non-small cell lung cancer: A single-arm phase II study.
    Lou, Yanni
    Jia, Liqun
    Liu, Qing
    Li, Liya
    Cui, Huijuan
    Deng, Chao
    Liu, Meng
    Su, Fei
    Cheng, Zhiqiang
    Wan, Donggui
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Clinical observation of Pemetrexed first-line treatment in advanced non-squamous lung cancer or non-small cell lung cancer without driver-mutations: a phase 2, single-arm trial
    Sha, Zhou
    He, Jian-Bo
    Jiang, Qinling
    Xu, Linlin
    Hu, Liyang
    Liang, Zibin
    Li, Tin
    Lin, Zhong
    Yu, Qitao
    Pei, Xiaofeng
    Lv, Weize
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (20)
  • [39] A Randomized, Phase II Study of Nimotuzumab Plus Gefitinib vs Gefitinib in Advanced Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy
    Kim, Hye Ryun
    Jang, Joung Soon
    Sun, Jong-Mu
    Ahn, Myung-Ju
    Kim, Dong-Wan
    Jung, Inkyung
    Moon, Yong-Wha
    Lim, Sun Min
    Jeong, Jae Heon
    Lee, Ki Hyeong
    Kim, Joo-Hang
    Lee, Dae Ho
    Kim, Sang-We
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S663 - S664
  • [40] Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: A single-arm, open-label, multicenter, phase II study
    Shinoda, Masahiro
    Shinkai, Masaharu
    Hara, Yu
    Tomaru, Kouji
    Manabe, Saki
    Murakami, Syuji
    Saito, Haruhiro
    Kobayashi, Nobuaki
    Miyazawa, Naoki
    Nishikawa, Masanori
    Kaneko, Takeshi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 486 - 494
12345